Net profit of Marksans Pharma rose 15.80% to Rs 96.72 crore in the quarter ended September 2024 as against Rs 83.52 crore during the previous quarter ended September 2023. Sales rose 20.83% to Rs 641.92 crore in the quarter ended September 2024 as against Rs 531.24 crore during the previous quarter ended September 2023.
| Particulars | Quarter Ended |
| Sep. 2024 | Sep. 2023 | % Var. |
| Sales | 641.92 | 531.24 | 21 |
| OPM % | 21.14 | 21.45 | - |
| PBDT | 144.11 | 131.32 | 10 |
| PBT | 124.60 | 113.77 | 10 |
| NP | 96.72 | 83.52 | 16 |